Adenosine receptor ligands: Potential as therapeutic agents in asthma and COPD

被引:74
作者
Fozard, JR [1 ]
Hannon, JP [1 ]
机构
[1] Novartis Pharma AG, CH-4002 Basel, Switzerland
关键词
D O I
10.1006/pupt.1999.0191
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:111 / 114
页数:4
相关论文
共 47 条
[21]  
Jacobson Marlene A., 1997, P315
[22]   SPECIES-DIFFERENCES IN LIGAND AFFINITY AT CENTRAL A(3)-ADENOSINE RECEPTORS [J].
JI, XD ;
VONLUBITZ, D ;
OLAH, ME ;
STILES, GL ;
JACOBSON, KA .
DRUG DEVELOPMENT RESEARCH, 1994, 33 (01) :51-59
[23]  
Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1
[24]   Activation of A(3) adenosine receptors on human eosinophils elevates intracellular calcium [J].
Kohno, Y ;
Ji, XD ;
Mawhorter, SD ;
Koshiba, M ;
Jacobson, KA .
BLOOD, 1996, 88 (09) :3569-3574
[25]   Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A(2a) receptor [J].
Ledent, C ;
Vaugeois, JM ;
Schiffmann, SN ;
Pedrazzini, T ;
ElYacoubi, M ;
Vanderhaeghen, JJ ;
Costentin, J ;
Heath, JK ;
Vassart, G ;
Parmentier, M .
NATURE, 1997, 388 (6643) :674-678
[26]   INHIBITION OF HUMAN MONOCYTE TNF PRODUCTION BY ADENOSINE RECEPTOR AGONISTS [J].
LEVRAUX, V ;
CHEN, YL ;
MASSON, I ;
DESOUSA, M ;
GIROUD, JP ;
FLORENTIN, I ;
CHAUVELOTMOACHON, L .
LIFE SCIENCES, 1993, 52 (24) :1917-1924
[27]   CLONED ADENOSINE A(3) RECEPTORS - PHARMACOLOGICAL PROPERTIES, SPECIES-DIFFERENCES AND RECEPTOR FUNCTIONS [J].
LINDEN, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (08) :298-306
[28]  
MARQUARDT DL, 1997, ASTHMA, P585
[29]   DNA antisense therapy for asthma in an animal model [J].
Nyce, JW ;
Metzger, WJ .
NATURE, 1997, 385 (6618) :721-725
[30]   Pharmacology of adenosine A(2A) receptors [J].
Ongini, E ;
Fredholm, BB .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (10) :364-372